ID

29358

Description

Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01131546

Link

https://clinicaltrials.gov/show/NCT01131546

Keywords

Versions (1)
  1. 3/20/18 3/20/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 20, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Essential Hypertension NCT01131546

English

Eligibility Essential Hypertension NCT01131546

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female outpatients, 18-75 years
Description

Outpatients | Age

Data type

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
patients with mild to moderate essential hypertension (defined as mean bp of 2 visits
Description

Essential Hypertension Mild | Essential Hypertension Moderate

Data type

boolean

Alias
UMLS CUI [1,1]
C0085580
UMLS CUI [1,2]
C2945599
UMLS CUI [2,1]
C0085580
UMLS CUI [2,2]
C0205081
≥140mm/90mmhg, and < 180mm/110mmhg)
Description

Mean blood pressure Visit Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0428886
UMLS CUI [1,2]
C1512346
UMLS CUI [1,3]
C1265611
written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with secondary hypertension
Description

Secondary hypertension

Data type

boolean

Alias
UMLS CUI [1]
C0155616
patients with severe hypertension
Description

Hypertension, severe

Data type

boolean

Alias
UMLS CUI [1]
C4013784
have to take other drugs that can influence blood pressure during the study
Description

Pharmaceutical Preparations Influence Blood Pressure

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C4054723
UMLS CUI [1,3]
C0005823
allergic to dhp calcium antagonists
Description

Hypersensitivity Dihydropyridine Calcium Channel Blocker

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2945601
evidence of congestive heart failure, unstable angina or severe arrhythmia
Description

Congestive heart failure | Angina, Unstable | Cardiac Arrhythmia Severe

Data type

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0002965
UMLS CUI [3,1]
C0003811
UMLS CUI [3,2]
C0205082
renal or hepatic dysfunction
Description

Renal dysfunction | Liver Dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0086565
women who are taking contraceptive pills or are likely to be pregnant
Description

Contraceptives, Oral | Pregnancy Probably

Data type

boolean

Alias
UMLS CUI [1]
C0009905
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0750492
participate in other clinical trials within 3 months prior to this study
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
Back to the top of the page

Similar models

Eligibility Essential Hypertension NCT01131546

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age
Item
male or female outpatients, 18-75 years
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Essential Hypertension Mild | Essential Hypertension Moderate
Item
patients with mild to moderate essential hypertension (defined as mean bp of 2 visits
boolean
C0085580 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C0085580 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
Mean blood pressure Visit Quantity
Item
≥140mm/90mmhg, and < 180mm/110mmhg)
boolean
C0428886 (UMLS CUI [1,1])
C1512346 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Secondary hypertension
Item
patients with secondary hypertension
boolean
C0155616 (UMLS CUI [1])
Hypertension, severe
Item
patients with severe hypertension
boolean
C4013784 (UMLS CUI [1])
Pharmaceutical Preparations Influence Blood Pressure
Item
have to take other drugs that can influence blood pressure during the study
boolean
C0013227 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
C0005823 (UMLS CUI [1,3])
Hypersensitivity Dihydropyridine Calcium Channel Blocker
Item
allergic to dhp calcium antagonists
boolean
C0020517 (UMLS CUI [1,1])
C2945601 (UMLS CUI [1,2])
Congestive heart failure | Angina, Unstable | Cardiac Arrhythmia Severe
Item
evidence of congestive heart failure, unstable angina or severe arrhythmia
boolean
C0018802 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0003811 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Renal dysfunction | Liver Dysfunction
Item
renal or hepatic dysfunction
boolean
C3279454 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
Contraceptives, Oral | Pregnancy Probably
Item
women who are taking contraceptive pills or are likely to be pregnant
boolean
C0009905 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0750492 (UMLS CUI [2,2])
Study Subject Participation Status
Item
participate in other clinical trials within 3 months prior to this study
boolean
C2348568 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial